Raymond H. Cypess, DVM, PhD
“There’s so much more to ATCC than meets the eye. Our work touches virtually every aspect of American life, benefiting society, the environment, and human health. For nearly a century, it’s been a driving force in the advancement of sound, reproducible science. And I’m proud to have played a leading role over the changing years in guiding this organization, which has become a pillar of scientific integrity and discovery.”
Dr. Cypess brings a unique blend of business acumen and fiscal responsibility to his role as chairman and CEO of ATCC and ATCC Global. His visionary approach and use of innovative, nontraditional strategies in the management of the nonprofit/for-profit corporate structure have enabled him to effectively guide the organization, reimagining its financial foundation so as to ensure its long-term viability, continued growth, and ongoing contributions to the progression of credible science.
In his capacity as a researcher, Dr. Cypess has served as principal investigator on numerous grants and contracts, including the Malaria Research and Reference Reagent Resource Center (MR4) and the Biodefense and Emerging Infections Resources repository (BEI Resources) from the National Institute of Allergy and Infectious Diseases (NIAID).
Dr. Cypess joined ATCC from the University of Tennessee, Memphis, where he was dean of the College of Graduate Health Sciences, professor of microbiology, immunology and comparative medicine, and vice provost for research and research training. During his leadership there, he created two new academic service departments: Biomedical Engineering and Comparative Medicine. In addition, he developed centerwide core infrastructure units, led a successful strategy that significantly increased the research funding of the university, and was awarded the University of Tennessee Memphis College of Medicine Outstanding Teacher Award five years running (1989–1993). Earlier in his career, he was an associate professor of epidemiology and microbiology at the University of Pittsburgh School of Public Health and professor and chairman at the New York State College of Veterinary Medicine.
Dr. Cypess participated on the scientific review boards of NIAID, was part of various National Institutes of Health study sections, and served on several editorial boards. He is the author of more than 80 chapters, reviews and journal articles; a fellow in the Infectious Disease Society; and a member of the American Epidemiology Society. He has served on boards for the New York Stock Exchange and NASDAQ corporations and has been director and treasurer of the Virginia Biotechnology Authority.
Dr. Cypess holds a doctorate in veterinary medicine from the University of Illinois and a doctorate in parasitology from the University of North Carolina.